| Literature DB >> 28929343 |
Emma J Stevenson1, Anthony Watson2, Stephan Theis3, Anja Holz3, Liam D Harper4, Mark Russell5.
Abstract
PURPOSE: The performance and physiological effects of isomaltulose and maltodextrin consumed intermittently during prolonged soccer-specific exercise were investigated.Entities:
Keywords: Carbohydrate; Extra-time; Football; Half-time; Rebound hypoglycaemia
Mesh:
Substances:
Year: 2017 PMID: 28929343 PMCID: PMC5700989 DOI: 10.1007/s00421-017-3719-5
Source DB: PubMed Journal: Eur J Appl Physiol ISSN: 1439-6319 Impact factor: 3.078
Fig. 1Overview of main trial procedures
Fig. 2Blood glucose (a) and plasma insulin (b) concentrations throughout the PSE (black solid line), MDX (black dashed line) and PLA (grey dashed line) trials (n = 22, data are presented as mean ± SD). *Significant difference between PSE and PLA at corresponding time-point; a represents significant difference between PSE and MDX at corresponding time-point; b represents significant difference between MDX and PLA at corresponding time-point
Lactate, glycerol, NEFA, IL-6, plasma osmolality and epinephrine responses (n = 22, data are presented as means ± SD)
| Variable | Trial | Timing | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest | Pre | 15-min | 30-min | 45-min | HT | 60-min | 75-min | 90-min | 105-min | 120-min | ||
| Lactate (mmol l−1) | PSE | 0.83 ± 0.35 | 0.80 ± 0.18 | 5.59 ± 2.17 | 5.13 ± 2.03 | 5.02 ± 2.08 | 2.16 ± 0.94 | 4.16 ± 2.11 | 3.89 ± 1.86 | 4.05 ± 2.01 | 2.92 ± 1.14 | 3.15 ± 1.42 |
| MDX | 0.77 ± 0.23 | 0.91 ± 0.28 | 5.52 ± 2.03 | 5.51 ± 1.86 | 5.26 ± 1.96 | 2.42 ± 1.20 | 4.56 ± 1.76 | 4.19 ± 1.51 | 4.66 ± 1.99 | 3.29 ± 1.49 | 3.67 ± 1.62 | |
| PLA | 0.79 ± 0.26 | 0.85 ± 0.21 | 5.42 ± 2.41 | 5.44 ± 2.33 | 4.94 ± 2.23 | 2.17 ± 1.06 | 4.39 ± 1.87 | 3.97 ± 1.70 | 4.10 ± 2.13 | 3.25 ± 1.60 | 3.73 ± 1.73 | |
| Glycerol (mmol l−1) | PSE | 0.03 ± 0.01 | 0.02 ± 0.02 | 0.06 ± 0.02 | 0.07 ± 0.03 | 0.09 ± 0.04* | 0.07 ± 0.03 | 0.12 ± 0.06* | 0.14 ± 0.04* | 0.17 ± 0.05* | 0.19 ± 0.07* | 0.27 ± 0.09* |
| MDX | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.07 ± 0.04 | 0.08 ± 0.04 | 0.09 ± 0.04* | 0.08 ± 0.03 | 0.09 ± 0.04* | 0.14 ± 0.05* | 0.16 ± 0.07* | 0.23 ± 0.08* | 0.30 ± 0.07* | |
| PLA | 0.03 ± 0.03 | 0.02 ± 0.01 | 0.08 ± 0.03 | 0.09 ± 0.03 | 0.11 ± 0.05 | 0.09 ± 0.03 | 0.15 ± 0.04 | 0.19 ± 0.07 | 0.26 ± 0.06 | 0.29 ± 0.08 | 0.36 ± 0.09 | |
| NEFA (mmol l−1) | PSE | 0.23 ± 0.12* | 0.06 ± 0.03*a | 0.17 ± 0.11* | 0.18 ± 0.17* | 0.30 ± 0.26* | 0.64 ± 0.38 | 0.49 ± 0.37* | 0.58 ± 0.32 | 0.75 ± 0.44* | 0.95 ± 0.47* | 1.22 ± 0.47* |
| MDX | 0.32 ± 0.19 | 0.09 ± 0.04* | 0.16 ± 0.13* | 0.18 ± 0.11* | 0.26 ± 0.16* | 0.71 ± 0.41 | 0.31 ± 0.19* | 0.54 ± 0.28* | 0.59 ± 0.25* | 0.95 ± 0.37* | 1.34 ± 0.38 | |
| PLA | 0.46 ± 0.30 | 0.10 ± 0.07 | 0.25 ± 0.15 | 0.27 ± 0.18 | 0.44 ± 0.25 | 0.81 ± 0.38 | 0.70 ± 0.30 | 0.80 ± 0.41 | 1.03 ± 0.38 | 1.24 ± 0.40 | 1.50 ± 0.42 | |
| IL-6 (pg ml−1) | PSE | 3.66 ± 1.93 | 3.52 ± 2.31 | 4.10 ± 2.06 | 4.15 ± 2.17 | 4.85 ± 2.57 | 5.19 ± 1.97 | 5.41 ± 2.58 | 6.07 ± 2.90 | 8.18 ± 3.47 | 9.57 ± 3.95 | 11.47 ± 5.54 |
| MDX | 4.32 ± 2.50 | 4.63 ± 2.57 | 4.79 ± 2.47 | 5.85 ± 2.56 | 6.34 ± 2.66 | 6.81 ± 3.61 | 7.10 ± 2.99 | 7.61 ± 3.40 | 8.87 ± 3.90 | 11.63 ± 4.67 | 14.99 ± 9.52 | |
| PLA | 3.74 ± 2.32 | 4.49 ± 2.41 | 5.36 ± 3.85 | 5.43 ± 2.33 | 7.38 ± 5.95 | 7.23 ± 3.42 | 6.85 ± 3.25 | 7.09 ± 2.34 | 9.56 ± 3.85 | 10.16 ± 3.72 | 14.32 ± 5.74 | |
| Osmolality (mOsmol kg−1) | PSE | 274 ± 41 | 283 ± 33 | 279 ± 38a | 290 ± 37 | 292 ± 38 | 276 ± 33 | 292 ± 47 | 297 ± 16 | 296 ± 13 | 300 ± 11 | 294 ± 6a |
| MDX | 284 ± 13 | 296 ± 16 | 304 ± 15* | 296 ± 16 | 287 ± 26 | 290 ± 10 | 292 ± 12 | 300 ± 21 | 288 ± 21 | 299 ± 17 | 285 ± 9* | |
| PLA | 292 ± 12 | 298 ± 12 | 293 ± 23 | 295 ± 17 | 293 ± 14 | 290 ± 13 | 294 ± 9 | 297 ± 9 | 299 ± 10 | 292 ± 10 | 296 ± 17 | |
| Epinephrine (pmol l−1) | PSE | – | 255.6 ± 89.0 | – | – | 464.5 ± 257.0 | 274.6 ± 116.0 | 589.8 ± 311.4 | – | 586.1 ± 349.6*a | – | 996.3 ± 611.9* |
| MDX | – | 285.3 ± 80.1 | – | – | 470.8 ± 205.9 | 326.3 ± 106.9 | 681.2 ± 561.4 | – | 877.8 ± 484.5 | – | 1397.2 ± 775.2* | |
| PLA | – | 253.6 ± 84.3 | – | – | 695.4 ± 555.0 | 288.6 ± 82.5 | 627.9 ± 217.7 | – | 1313.7 ± 975.4 | – | 3149.5 ± 2265.1 | |
*Significant difference compared to PLA at corresponding time-point
aSignificant difference compared to MDX at corresponding time-point
Peak HR, mean HR, RPE and abdominal discomfort responses (n = 22, data are presented as means ± SD)
| Variable | Trial | Timing | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 0–15 min | 15–30 min | 30–45 min | 45–60 min | 60–75 min | 75–90 min | 90–105 min | 105–120 min | ||
| Peak HR (beats min−1) | PSE | 184 ± 9 | 184 ± 9 | 183 ± 8 | 184 ± 7 | 188 ± 13 | 188 ± 13 | 184 ± 8 | 189 ± 12 |
| MDX | 188 ± 10 | 187 ± 8 | 186 ± 8 | 186 ± 9 | 188 ± 9 | 187 ± 9 | 186 ± 10 | 189 ± 9 | |
| PLA | 184 ± 11 | 183 ± 11 | 184 ± 10 | 183 ± 10 | 185 ± 10 | 185 ± 9 | 184 ± 9 | 187 ± 10 | |
| Mean HR (beats min−1) | PSE | 159 ± 9 | 158 ± 11 | 159 ± 10 | 160 ± 7 | 158 ± 10 | 160 ± 11 | 159 ± 9 | 161 ± 10 |
| MDX | 164 ± 11 | 162 ± 11 | 163 ± 10 | 161 ± 11 | 163 ± 11 | 162 ± 11 | 164 ± 10 | 163 ± 10 | |
| PLA | 161 ± 13 | 159 ± 15 | 159 ± 16 | 160 ± 11 | 161 ± 14 | 161 ± 12 | 162 ± 12 | 164 ± 13 | |
| RPE (units) | PSE | 11.6 ± 1.9 | 12.8 ± 1.6 | 13.4 ± 1.3 | 13.2 ± 1.4 | 14.5 ± 1.1 | 15.1 ± 1.4 | 15.4 ± 1.6 | 16.7 ± 1.9 |
| MDX | 11.3 ± 1.8 | 12.6 ± 1.4 | 13.3 ± 1.4 | 12.7 ± 1.6 | 14.1 ± 1.6 | 14.8 ± 1.6 | 15.2 ± 2.1 | 16.6 ± 2.1 | |
| PLA | 11.6 ± 2.1 | 12.9 ± 2.0 | 13.5 ± 1.8 | 13.2 ± 1.9 | 14.4 ± 2.0 | 15.1 ± 1.9 | 15.5 ± 1.9 | 16.8 ± 2.0 | |
| Abdominal discomfort (units) | PSE | 1.6 ± 1.4 | 2.3 ± 1.8 | 2.4 ± 1.6 | 2.3 ± 1.5 | 2.5 ± 1.7 | 2.9 ± 1.8 | 3.2 ± 1.8 | 3.7 ± 2.0 |
| MDX | 1.6 ± 0.9 | 2.2 ± 1.3 | 2.5 ± 1.4 | 2.3 ± 1.5 | 2.5 ± 1.5 | 2.9 ± 1.7 | 3.1 ± 1.8 | 4.0 ± 2.2 | |
| PLA | 1.6 ± 1.2 | 2.2 ± 1.4 | 2.5 ± 1.5 | 2.4 ± 1.5 | 3.0 ± 1.6 | 3.5 ± 1.8 | 3.6 ± 1.9 | 4.4 ± 2.3 | |
Peak 20-m sprint velocity, sprint decrement index, jump height, shot speed, shot precision and shot success responses (n = 22, data are presented as means ± SD)
| Variable | Trial | Timing | ||||
|---|---|---|---|---|---|---|
| Pre 1st half | Post 1st half | Pre 2nd half | Post 2nd half | Post extra-time | ||
| Peak 20-m sprint velocity (m s−1) | PSE | 6.27 ± 0.27 | 6.15 ± 0.33 | 5.98 ± 0.32 | 5.98 ± 0.38 | 5.82 ± 0.51 |
| MDX | 6.24 ± 0.27 | 6.12 ± 0.31 | 5.98 ± 0.27 | 5.97 ± 0.38 | 5.77 ± 0.53 | |
| PLA | 6.26 ± 0.29 | 6.14 ± 0.29 | 6.00 ± 0.29 | 6.11 ± 0.34 | 5.84 ± 0.47 | |
| Sprint decrement index (%) | PSE | 3.5 ± 2.1 | 3.0 ± 1.4 | 4.8 ± 4.0 | 5.1 ± 2.8 | 5.8 ± 4.1 |
| MDX | 3.5 ± 2.2 | 5.1 ± 3.5 | 4.6 ± 2.8 | 3.9 ± 2.5 | 5.6 ± 3.8 | |
| PLA | 3.8 ± 2.1 | 3.9 ± 2.7 | 4.1 ± 3.0 | 6.4 ± 4.0 | 6.5 ± 5.2 | |
| Jump height (cm) | PSE | 34.5 ± 4.4 | 34.0 ± 4.4 | 32.6 ± 5.0 | 33.2 ± 4.3 | 32.1 ± 5.3 |
| MDX | 33.9 ± 4.8 | 34.1 ± 5.7 | 32.3 ± 5.3 | 33.7 ± 5.8 | 33.1 ± 6.0 | |
| PLA | 33.7 ± 4.8 | 34.7 ± 5.3 | 32.6 ± 5.6 | 33.9 ± 6.1 | 33.2 ± 6.1 | |
| Shot speed (m s−1) | PSE | 18.9 ± 2.0 | 18.7 ± 2.0 | 18.0 ± 2.1 | 18.5 ± 1.9 | 18.0 ± 1.9 |
| MDX | 18.2 ± 2.2 | 17.9 ± 1.9 | 18.2 ± 1.7 | 17.6 ± 1.6 | 17.8 ± 2.0 | |
| PLA | 18.7 ± 2.3 | 18.3 ± 2.4 | 17.9 ± 2.5 | 18.4 ± 2.3 | 17.6 ± 2.5 | |
| Shot precision (cm) | PSE | 132 ± 54 | 138 ± 70 | 146 ± 67 | 121 ± 36 | 156 ± 64 |
| MDX | 139 ± 53 | 118 ± 62 | 153 ± 74 | 121 ± 54 | 128 ± 53 | |
| PLA | 124 ± 52 | 116 ± 51 | 137 ± 64 | 143 ± 52 | 120 ± 63 | |
| Shot success (%) | PSE | 67 ± 25 | 65 ± 21 | 76 ± 20 | 78 ± 21 | 69 ± 24 |
| MDX | 66 ± 21 | 67 ± 20 | 64 ± 29 | 72 ± 22 | 74 ± 24 | |
| PLA | 67 ± 22 | 69 ± 20 | 74 ± 25 | 75 ± 20 | 66 ± 20 | |
Mean 15-m sprint velocity, dribbling speed, dribbling precision and dribbling success responses (n = 22, data are presented as means ± SD)
| Variable | Trial | Timing | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 0–15 min | 15–30 min | 30–45 min | 45–60 min | 60–75 min | 75–90 min | 90–105 min | 105–120 min | ||
| Mean 15-m sprint velocity (m s−1) | PSE | 5.58 ± 0.36 | 5.48 ± 0.35 | 5.48 ± 0.34 | 5.40 ± 0.35 | 5.28 ± 0.38 | 5.19 ± 0.41 | 5.09 ± 0.42 | 4.97 ± 0.50 |
| MDX | 5.54 ± 0.37 | 5.43 ± 0.39 | 5.37 ± 0.41 | 5.29 ± 0.32 | 5.21 ± 0.35 | 5.15 ± 0.37 | 5.00 ± 0.40 | 4.84 ± 0.48 | |
| PLA | 5.62 ± 0.38 | 5.56 ± 0.43 | 5.45 ± 0.41 | 5.44 ± 0.39 | 5.26 ± 0.31 | 5.16 ± 0.33 | 5.06 ± 0.30 | 4.89 ± 0.32 | |
| Dribbling speed (m s−1) | PSE | 3.2 ± 0.3 | 3.2 ± 0.2 | 3.2 ± 0.4 | 3.2 ± 0.2 | 3.3 ± 0.3 | 3.2 ± 0.4 | 3.3 ± 0.3 | 3.0 ± 0.3 |
| MDX | 3.3 ± 0.4 | 3.2 ± 0.2 | 3.2 ± 0.3 | 3.3 ± 0.4 | 3.3 ± 0.4 | 3.2 ± 0.4 | 3.2 ± 0.3 | 3.1 ± 0.3 | |
| PLA | 3.2 ± 0.3 | 3.2 ± 0.2 | 3.1 ± 0.2 | 3.2 ± 0.2 | 3.2 ± 0.2 | 3.2 ± 0.3 | 3.1 ± 0.2 | 3.1 ± 0.3 | |
| Dribbling precision (cm) | PSE | 42 ± 13 | 41 ± 10 | 40 ± 11 | 40 ± 10 | 35 ± 9 | 35 ± 8 | 37 ± 6 | 37 ± 11 |
| MDX | 44 ± 8 | 40 ± 8 | 41 ± 8 | 38 ± 8 | 36 ± 10 | 35 ± 10 | 37 ± 9 | 36 ± 9 | |
| PLA | 41 ± 8 | 37 ± 8 | 37 ± 8 | 34 ± 7 | 33 ± 8 | 35 ± 9 | 34 ± 8 | 34 ± 7 | |
| Dribbling success (%) | PSE | 91 ± 9 | 80 ± 15 | 92 ± 11 | 93 ± 6 | 88 ± 11 | 86 ± 12 | 89 ± 8 | 79 ± 14 |
| MDX | 90 ± 8 | 90 ± 13 | 90 ± 13 | 94 ± 8 | 93 ± 8 | 90 ± 13 | 90 ± 11 | 87 ± 10 | |
| PLA | 90 ± 8 | 89 ± 8 | 91 ± 11 | 93 ± 8 | 86 ± 15 | 86 ± 13 | 88 ± 11 | 90 ± 8 | |